FDA ap­proves Bris­tol My­ers and Karuna's schiz­o­phre­nia drug, in mile­stone for psy­chi­a­try

The FDA on Thurs­day ap­proved Bris­tol My­ers Squibb’s new schiz­o­phre­nia drug in one of the year’s most an­tic­i­pat­ed reg­u­la­to­ry de­ci­sions.

The ap­proval gives Bris­tol My­ers …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER